Zhejiang Chinese Medical University, International Translational Neuroscience Research Institute
548, Binwen Road, Hangzhou, P.R. China, 310053

The university is one of the first universities in China to recruit and train graduate students of traditional Chinese medicine, and one of the first universities in Zhejiang Province to obtain the right to confer doctoral degrees and post doctoral research stations. The existing doctoral degree programs of the University cover three first-class disciplines: Traditional Chinese medicine, integrated traditional Chinese and Western medicine, and traditional Chinese medicine; The master’s degree covers 10 first-class disciplines: Traditional Chinese medicine, integrated traditional Chinese and Western medicine, traditional Chinese medicine, basic medicine, clinical medicine, pharmacy, medical technology, nursing, Marxist theory, public health and preventive medicine. Professional degrees include doctor and master of traditional Chinese medicine, master of clinical medicine, master of Stomatology, master of public health, master of nursing, master of traditional Chinese medicine, master of public administration, master of biology and medicine, and master of pharmacy. There are three post doctoral research stations of traditional Chinese medicine, traditional Chinese medicine and integrated traditional and Western medicine. At present, there are more than 20000 full-time students (including independent colleges), including more than 3700 master’s and doctoral students and more than 800 international students with academic qualifications

Representative: Prof. Vladimir Parpura

Vladimir Parpura, MD, PhD, MAE, holds both a medical degree, awarded from the University of Zagreb in Croatia in 1989, and a doctorate, received in Neuroscience and Zoology from Iowa State University in 1993. He held faculty appointments at the Department of Zoology and Genetics, Iowa State University; the Department of Cell Biology and Neuroscience, University of California Riverside; the Department of Biotechnology, University of Rijeka, Croatia and the Department of Neurobiology, University of Alabama at Birmingham, U.S.A. He is presently a Distinguished Professor and Director of the International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou, China; and a Cheung Kong Scholar and Kun Peng Action Expert. He has been elected/inducted as a Member of Academia Europaea (MAE) in 2012, of Dana Alliance for Brain Initiatives in 2016, a corresponding member of the Slovenian Academy of Sciences and Arts (MSASA) as well as a Fellow of the American Association for the Advancement of Science (FAAAS) both in 2017, and a Fellow of the American Physiological Society (FAPS) in 2020. He received the 2017-2018 McNulty Civitan Scientist Award given by The UAB Civitan International Research Center and The Chesapeake District of Civitan International. Parpura was the 25th President (2017-2019 term) of the American Society for Neurochemistry. He served on the Council of the International Society for Neurochemistry (2019-2023 term). In 2019, Parpura was awarded the Honorary Professor title at the University of Rijeka, Croatia and the journal Neurochemical Research had a special issue in October of 2021 in his honor. In 2013, his laboratory ranked 3rd in the world in nanotechnology. Since 2021, he has ranked number 2 in the world in astrocyte expertise by expertscape.com. He discovered the astrocyte-neuron glutamate-mediated signalling pathway; i.e., gliotransmission. This led to the concept of the tripartite synapse whereby astrocytes, by releasing a gliotransmitter, can modulate synaptic transmission and plasticity. Subsequently, gliotransmission has proven to be important for biological processes, including sleep, respiration, learning, memory, gut motility and secretion. Parpura has been interfacing neuroscience with nanoscience/nanotechnology, neurochemistry, synthetic biology and biomedical engineering.

https://scholar.google.com/citations?hl=en&user=ekvKLtMAAAAJ